SGN Trademark

Trademark Overview

On Tuesday, January 24, 2023, a trademark application was filed for SGN with the United States Patent and Trademark Office. The USPTO has given the SGN trademark a serial number of 97766451. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, September 18, 2025. This trademark is owned by Seagen Inc.. The SGN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the treatment of cancer and immunological diseases
sgn

General Information

Serial Number97766451
Word MarkSGN
Filing DateTuesday, January 24, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, September 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical research and development services; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the treatment of cancer and immunological diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeagen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98021
Party NameSeagen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98021

Trademark Events

Event DateEvent Description
Friday, January 27, 2023NEW APPLICATION ENTERED
Monday, February 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 20, 2023ASSIGNED TO EXAMINER
Saturday, October 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, April 7, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 27, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 21, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 30, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 30, 2024SOU EXTENSION 1 FILED
Monday, September 30, 2024SOU EXTENSION 1 GRANTED
Tuesday, April 8, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2025SOU EXTENSION 2 GRANTED
Thursday, September 18, 2025SOU EXTENSION 3 FILED
Thursday, September 18, 2025SOU EXTENSION 3 GRANTED
Friday, September 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 18, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2025SOU EXTENSION 2 FILED
Wednesday, April 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

research pharmaceutical development treatment tests immunological diseases diagnostic cancer drug